Navigation Links
New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
Date:11/14/2007

- First Study to Demonstrate Survival Benefit with ERBITUX in Patients with

Colorectal Cancer Refractory to All Approved Chemotherapies -

NEW YORK, Nov. 14 /PRNewswire-FirstCall/ -- ImClone Systems Incorporated (Nasdaq: IMCL) and Bristol-Myers Squibb Company (NYSE: BMY) announced today results from a multicenter, open-label, randomized Phase III trial, published in the New England Journal of Medicine, in which ERBITUX(R) (cetuximab) as a single agent demonstrated a significant improvement in overall survival in patients with metastatic colorectal cancer (mCRC) refractory to approved chemotherapy agents. The study compared ERBITUX plus best supportive care (BSC) to BSC alone in patients with mCRC whose disease had progressed through treatment with all approved chemotherapy, including irinotecan, oxaliplatin, and fluoropyrimidines.

The independent study (NCIC CTG CO.17), conducted by the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) in collaboration with the Australasian Gastro-Intestinal Trials Group (AGITG), involved 572 patients and demonstrated that treating patients with ERBITUX as a monotherapy plus BSC significantly increased overall survival compared to BSC alone. BSC included palliative therapies designed to alleviate pain and treat other effects caused by mCRC.

"This is the first time an antibody used as a single agent in colorectal cancer has demonstrated an overall survival benefit. These outcomes add to the growing body
'/>"/>

SOURCE Bristol-Myers Squibb; ImClone Systems Incorporated
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
2. Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless, States SafeMinds
3. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
4. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
5. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
6. Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal Transfusion
7. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
8. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
9. Risks Associated With Face Transplants May Be Lower Than Previously Thought, ASPS Journal Review Suggests
10. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
11. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...v. 25 The FDA granted traditional ... a non-nucleoside reverse transcriptase inhibitor ...indicated for use in treatment-experienced adults ...strains resistant to an NNRTI and other antiretrov...sed on 48-week data from two Phase 3 studies known...
(Date:11/25/2009)..., Nov. 25 Regado Biosciences, a pr...tithrombotic aptamers with active control agents, ..., will be presenting at the Piper Jaffray 21st Ann...Hotel in New York City. Dr. Mazzo,s presentation ... 1 and will include an overview of the Company,s p...
(Date:11/25/2009)...ov. 25 Abaxis, Inc. (Nas...ring point-of-care blood analysis systems, announc...xecutive officer, will present at the 21st Annual ... December 2, 2009 at 2:00 p.m. ET. The conference ...ork City. ,, About Abaxis ,, Abaxis devel...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Democratic National Committee Chairman Tim Kaines Statement on the Senates Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 61882 1Democratic National Committee Chairman Tim Kaines Statement on the Senates Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 61882 2River Blindness 28Onchocerciasis 29 Reduced By Nearly One Third In At Risk Populations In Six Countries 61879 1River Blindness 28Onchocerciasis 29 Reduced By Nearly One Third In At Risk Populations In Six Countries 61879 2River Blindness 28Onchocerciasis 29 Reduced By Nearly One Third In At Risk Populations In Six Countries 61879 3River Blindness 28Onchocerciasis 29 Reduced By Nearly One Third In At Risk Populations In Six Countries 61879 4This is a Test From PR Newswire Immediate Direct File 61877 1
...s, Inc.,announced today that it has successfully c... system, the newest addition to the company,s prod... in which degenerative changes in,the facet joints...neurological symptoms in the legs. Traditionally, ...ndergo decompressive laminectomy surgery, which is...
...sdaq: VICL ) today announced the release to telev... produced video report featuring metastatic,melano...7(R),immunotherapeutic product candidate. The repo...ities with clinical sites participating in Vical,s...s by stations promoting,melanoma awareness in May,...
Other Medicine Technology:First Human Implant of New Archus Orthopedics Facet Replacement System 2Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 2Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 3Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 4Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 5
(Date:11/27/2009)..., ROCHESTER, N.Y., Nov. 27 /PRNewswire-USNewswi...lth care provider and fortunately every year, new ...ention. But do all vaccines boost immunity for the...onal ,booster shots, needed to keep immunity stron...e Journal of the American Academy of Pediatrics, M...
(Date:11/27/2009)... rates to bring unprecedented medical, economic bu...7 (HealthDay News) -- The number of people with di...over the next 25 years, a new study predicts. ,...million people with the disease, up from 23.7 mill...ating people with diabetes will triple, the study ...
(Date:11/27/2009)... Three new interactive anatomy e...s & Wilkins expand health sciences learning op... Durham, NC (Vocus) November 27, 200...; Wilkins (LWW), a division of Wolters Kluwer Heal...anatomy education apps on the App Store. Clemente&...
(Date:11/26/2009)... that,s too big or too heavy can lead to strains o... News) -- There may be nothing wrong with stuffing...ant to do the same thing with your suitcase as you...ple were treated in 2008 in U.S. hospital emergenc...al facilities for luggage-related injuries, such a...
(Date:11/26/2009)... Benton Communications announces...owth system for retailers struggling to make an ec...) November 26, 2009 -- Flu fears is the type of ch...e emergency room, according to Dr. David Benton, b...ased business growth system – The Rfactor I...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Pharmacist Injects Cure for Ailing Businesses 2
...Healthcare,REIT, Inc. today announced the acquisit...ocated at 5550 South East St., Epler Parke Buildin...building consisting of approximately,34,000 square... by Interstates 465 and,74, as well as State Highw...
...ion,(Nasdaq: IOMI ) today announced, in complianc...ent audit report included in the Company,s Annual,...Exchange Commission on,March 27, 2008 for the fisc...resent any change to the Company,s Annual,Report o...
...,ULU) today announced that it has scheduled a conf...ncial results and provide a general business updat...time., To participate in the conference call, ple...rence. If you are unable to,listen to the live bro...
...ional Underwriters, Inc. (Darwin) (NYSE: DR ) has...served as its senior vice president -,underwriting...ecome,associated with a competing professional lia...e president and chief underwriting,officer (CUO), ...
...llateral damage from blood sugar disease , ... the leading cause of heart disease, stroke, blind..., can also cause the lungs to deteriorate quicker ...in the April issue of Diabetes Care concluded th...
...nd,Senate poised to vote on the President,s Emerge...bill, a five-year, $50 billion initiative to,comba...ngress must address,the critical HIV prevention sh... million more,people have access to anti-retrovira...
Other Medicine News:Health News:Grubb & Ellis Healthcare REIT Acquires Epler Parke Building B in Indianapolis 2Health News:Grubb & Ellis Healthcare REIT Acquires Epler Parke Building B in Indianapolis 3Health News:ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2008 and Provide a Business Update 2Health News:Darwin Announces Departure of Senior Vice President 2Health News:Lung Capacity Declines Faster With Diabetes 2Health News:Lung Capacity Declines Faster With Diabetes 3Health News:Will Congress Do More for HIV Prevention? 2Health News:Will Congress Do More for HIV Prevention? 3Health News:Will Congress Do More for HIV Prevention? 4
Large External Fixator
Standard Tibial Fixator
DFS Dimension Distal Radius Fixation System
Adjustable Distal Radius Fixator
Medicine Products: